Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 5, 2012Clinical Infectious DiseasesOpen Access

Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAlfred SorbelloUnited States Food and Drug AdministrationSJS. Christopher JonesUnited States Food and Drug AdministrationWCW. Carter

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sorbello et al. (2012) studied this question.

synapsesocial.com/papers/6a011894e92f4a033c855ccahttps://doi.org/10.1093/cid/cis351
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans2009 · 3,065 citations
  2. 2BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design2000 · 384 citations
  3. 3The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza2009 · 185 citations
  4. 4Peramivir Use for Treatment of Hospitalized Patients With Influenza A(H1N1)pdm09 Under Emergency Use Authorization, October 2009-June 20102012 · 41 citations
  5. 5Fatalities Associated with the 2009 H1N1 Influenza A Virus in New York City2010 · 127 citations